Nanomedicine Approaches in Male Infertility Treatment: Targeted Drug Delivery and Sperm Function Enhancement

Male infertility affects a significant portion of the global population, contributing to nearly half of all infertility cases. Common underlying causes include disruptions in spermatogenesis, hormonal imbalances, and genetic anomalies. Traditional treatments, such as hormone therapy, surgical interventions, and assisted reproductive technologies, often exhibit limited efficacy due to their invasive nature, systemic side effects, and high financial costs. This study explores nanomedicine’s potential as a targeted approach to address these limitations, particularly through advanced nanoparticle-based drug delivery systems aimed at enhancing sperm function and improving fertility outcomes. Various types of nanoparticles, including liposomes, polymer-based nanoparticles, and metal nanoparticles, are assessed for their abilities to deliver therapeutic agents directly to spermatogenic cells and support cells in the testes. By modulating critical cellular pathways necessary for sperm production and survival, nanoparticles offer enhanced therapeutic effects with minimized systemic exposure. Additionally, the study highlights the potential of nanoparticle applications in personalized reproductive medicine, allowing for tailored treatment approaches based on individual profiles. Although further clinical trials are needed to confirm efficacy and safety, nanoparticle-based therapies offer a promising path forward in the minimally invasive, targeted treatment of male infertility.